Published in DNA Repair (Amst) on January 21, 2009
Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat Rev Cancer (2012) 2.52
DNA repair mechanisms in dividing and non-dividing cells. DNA Repair (Amst) (2013) 1.85
Multifaceted roles of alkyltransferase and related proteins in DNA repair, DNA damage, resistance to chemotherapy, and research tools. Chem Res Toxicol (2011) 1.30
Is neurodegenerative disease a long-latency response to early-life genotoxin exposure? Int J Environ Res Public Health (2011) 1.14
Kinetic mechanism for the flipping and excision of 1,N(6)-ethenoadenine by human alkyladenine DNA glycosylase. Biochemistry (2009) 1.05
The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner. PLoS One (2011) 1.01
O6-methylguanine induces altered proteins at the level of transcription in human cells. Nucleic Acids Res (2010) 0.98
Unraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators? Front Genet (2012) 0.92
Aag DNA glycosylase promotes alkylation-induced tissue damage mediated by Parp1. PLoS Genet (2013) 0.91
Establishment and characterization of Prnp knockdown neuroblastoma cells using dual microRNA-mediated RNA interference. Prion (2011) 0.91
Cigarette smoke induces DNA damage and alters base-excision repair and tau levels in the brain of neonatal mice. Toxicol Sci (2011) 0.86
The Response to Oxidative DNA Damage in Neurons: Mechanisms and Disease. Neural Plast (2016) 0.83
Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs. Future Med Chem (2012) 0.83
Evidence for base excision repair processing of DNA interstrand crosslinks. Mutat Res (2012) 0.80
Base excision repair in physiology and pathology of the central nervous system. Int J Mol Sci (2012) 0.78
Toxicity biomarkers among US children compared to a similar cohort in France: a blinded study measuring urinary porphyrins. Toxicol Environ Chem (2010) 0.78
Transcriptional profiling of the mouse hippocampus supports an NMDAR-mediated neurotoxic mode of action for benzo[a]pyrene. Environ Mol Mutagen (2016) 0.76
Animal models of brain maldevelopment induced by cycad plant genotoxins. Birth Defects Res C Embryo Today (2013) 0.76
MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst) (2007) 4.04
Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol (2004) 3.56
MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer (2004) 3.27
Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer (2007) 3.12
Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol (2001) 2.98
Effect of prenatal exposure to airborne polycyclic aromatic hydrocarbons on neurodevelopment in the first 3 years of life among inner-city children. Environ Health Perspect (2006) 2.63
Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J Neurosci Res (1995) 2.46
Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol (1994) 2.43
Repair of alkylated DNA: recent advances. DNA Repair (Amst) (2006) 2.34
Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc Natl Acad Sci U S A (1997) 2.01
DNA interstrand crosslink repair during G1 involves nucleotide excision repair and DNA polymerase zeta. EMBO J (2006) 1.89
Biomarkers in maternal and newborn blood indicate heightened fetal susceptibility to procarcinogenic DNA damage. Environ Health Perspect (2004) 1.80
Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair. Mol Cell Biol (2001) 1.76
DNA adducts from chemotherapeutic agents. Mutat Res (1996) 1.73
Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress. Cancer Res (2001) 1.66
Neurocognitive effects of treatment for childhood cancer. Ment Retard Dev Disabil Res Rev (2006) 1.52
PAH-DNA adducts in cord blood and fetal and child development in a Chinese cohort. Environ Health Perspect (2006) 1.42
DNA damage and mutagenesis induced by nitrogen mustards. Mutat Res (1994) 1.37
An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J Neurochem (1997) 1.36
DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis (1999) 1.28
The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase. Science (1993) 1.27
Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage Version 7. DNA Repair (Amst) (2005) 1.23
Quantitative associations between DNA damage in human placenta and maternal smoking and birth weight. J Natl Cancer Inst (1988) 1.19
3-Methyladenine DNA glycosylase-deficient Aag null mice display unexpected bone marrow alkylation resistance. Cancer Res (2002) 1.18
N-methylpurine DNA glycosylase overexpression increases alkylation sensitivity by rapidly removing non-toxic 7-methylguanine adducts. Nucleic Acids Res (2005) 1.15
Activation of bis-electrophiles to mutagenic conjugates by human O6-alkylguanine-DNA alkyltransferase. Chem Res Toxicol (2004) 1.10
Excision repair of nitrogen mustard-DNA adducts in Saccharomyces cerevisiae. Nucleic Acids Res (1999) 1.06
Relationship between polycyclic aromatic hydrocarbon-DNA adducts, environmental tobacco smoke, and child development in the World Trade Center cohort. Environ Health Perspect (2007) 1.05
Assessment of neuronal viability with Alamar blue in cortical and granule cell cultures. J Neurosci Methods (1996) 1.05
Cross-linking of the DNA repair protein Omicron6-alkylguanine DNA alkyltransferase to DNA in the presence of antitumor nitrogen mustards. Chem Res Toxicol (2008) 1.05
Comparison of the DNA-alkylating properties and mutagenic responses of a series of S-(2-haloethyl)-substituted cysteine and glutathione derivatives. Biochemistry (1990) 1.05
Identification of the cross-link between human O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA. Cancer Res (1992) 1.00
Long-term persistence of O6-methylguanine in rat brain DNA. Nature (1977) 0.99
Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain. Mol Chem Neuropathol (1997) 0.95
Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia. Am J Geriatr Psychiatry (2004) 0.95
Proteomic analysis of the genotoxicant methylazoxymethanol (MAM)-induced changes in the developing cerebellum. J Proteome Res (2006) 0.95
Lack of the DNA repair protein O6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors. Proc Natl Acad Sci U S A (1996) 0.94
Repair and mutagenesis at oxidized DNA lesions in the developing brain of wild-type and Ogg1-/- mice. Oncogene (2006) 0.91
Formation of O6-ethylthioethylguanine in DNA by reaction with the sulfur mustard, chloroethyl sulfide, and its apparent lack of repair by O6-alkylguanine-DNA alkyltransferase. Carcinogenesis (1986) 0.91
Mammalian 3-methyladenine DNA glycosylase protects against the toxicity and clastogenicity of certain chemotherapeutic DNA cross-linking agents. Cancer Res (1998) 0.91
Quantitative changes with age in the DNA content of methylazoxymethanol-induced microencephalic rat brain. J Neurochem (1972) 0.89
Oxoguanine glycosylase 1 protects against methamphetamine-enhanced fetal brain oxidative DNA damage and neurodevelopmental deficits. J Neurosci (2008) 0.89
Studies on methylazoxymethanol, the aglycone of cycasin: methylation of nucleic acids in vitro. Biochem J (1966) 0.89
The in vivo genetic activity profile of the monofunctional nitrogen mustard 2-chloroethylamine differs drastically from its bifunctional counterpart mechlorethamine. Carcinogenesis (2000) 0.88
Associations among genetic susceptibility, DNA damage, and pregnancy outcomes of expectant mothers exposed to environmental tobacco smoke. Sci Total Environ (2007) 0.86
Investigation of differentially expressed genes during the development of mouse cerebellum. Brain Res Gene Expr Patterns (2001) 0.86
O(6)-methylguanine DNA-methyltransferase (MGMT) overexpression in melanoma cells induces resistance to nitrosoureas and temozolomide but sensitizes to mitomycin C. Toxicol Appl Pharmacol (2005) 0.86
Change in expression of MGMT during maturation of human monocytes into dendritic cells. DNA Repair (Amst) (2007) 0.86
Neuronal migration disorders. Ment Retard Dev Disabil Res Rev (2001) 0.86
A rapid and sensitive assay for measuring mitochondrial metabolic activity in isolated neural tissue. Brain Res Brain Res Protoc (1998) 0.85
O6-methylguanine-DNA methyltransferase deficiency in developing brain: implications for brain tumorigenesis. DNA Repair (Amst) (2007) 0.84
Nitrogen mustard- and half-mustard-induced damage in Escherichia coli requires different DNA repair pathways. Mutat Res (2005) 0.84
3-Methyladenine DNA glycosylase is important for cellular resistance to psoralen interstrand cross-links. DNA Repair (Amst) (2008) 0.84
Role of nucleotide- and base-excision repair in genotoxin-induced neuronal cell death. DNA Repair (Amst) (2004) 0.83
Molecular networks perturbed in a developmental animal model of brain injury. Neurobiol Dis (2005) 0.80
Quantification of O6-methyl and O6-ethyl deoxyguanosine adducts in C57BL/6N/Tk+/- mice using LC/MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.80
Sensitivity to nitrogen mustard relates to the ability of processing DNA damage in Chinese hamster ovary cells. Pharmacol Toxicol (2000) 0.80
Cycad toxin-induced damage of rodent and human pancreatic beta-cells. Biochem Pharmacol (1995) 0.79
Base excision repair sensitizes cells to sulfur mustard and chloroethyl ethyl sulfide. DNA Repair (Amst) (2007) 0.78
Cytotoxicity and sister chromatid exchanges in 9L cells treated with monofunctional and bifunctional nitrogen mustards. Carcinogenesis (1987) 0.78
Genotoxicants target distinct molecular networks in neonatal neurons. Environ Health Perspect (2006) 0.78
Effect of O6-benzylguanine on nitrogen mustard-induced toxicity, apoptosis, and mutagenicity in Chinese hamster ovary cells. Mol Cancer Ther (2001) 0.77
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med (2001) 5.14
Global response of Saccharomyces cerevisiae to an alkylating agent. Proc Natl Acad Sci U S A (1999) 4.27
Regulatory networks revealed by transcriptional profiling of damaged Saccharomyces cerevisiae cells: Rpn4 links base excision repair with proteasomes. Mol Cell Biol (2000) 4.15
Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol (2000) 3.94
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant (2002) 3.24
Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol (1998) 3.08
Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med (1984) 3.07
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules. Br J Cancer (2003) 2.38
Molecular basis for discriminating between normal and damaged bases by the human alkyladenine glycosylase, AAG. Proc Natl Acad Sci U S A (2000) 2.36
Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant (1995) 2.35
Traumatic cervical Brown-Sequard and Brown-Sequard-plus syndromes: the spectrum of presentations and outcomes. Paraplegia (1991) 2.17
Side effects and the "blindability" of clinical drug trials. Am J Psychiatry (1992) 2.13
Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc Natl Acad Sci U S A (1997) 2.01
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet (1995) 1.85
Generation of a strong mutator phenotype in yeast by imbalanced base excision repair. Proc Natl Acad Sci U S A (1998) 1.82
3-methyladenine DNA glycosylases: structure, function, and biological importance. Bioessays (1999) 1.80
Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res (2000) 1.73
Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc Natl Acad Sci U S A (1999) 1.69
A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr Drug Metab (2005) 1.61
Antigen detection in the diagnosis of invasive aspergillosis. Utility in controlled, blinded trials. Ann Intern Med (1983) 1.59
Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol (1999) 1.55
Tandem B1 elements located in a mouse methylation center provide a target for de novo DNA methylation. J Biol Chem (1999) 1.53
Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF. J Clin Oncol (2000) 1.50
Polypharmacy in fatal clozapine-associated agranulocytosis. Lancet (1991) 1.50
DNA alkylation repair limits spontaneous base substitution mutations in Escherichia coli. J Bacteriol (1994) 1.48
Molecular genetic changes in human epithelial ovarian malignancies. Gynecol Oncol (1992) 1.48
Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res (1996) 1.47
Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents. Clin Cancer Res (1999) 1.46
Serodiagnosis of invasive aspergillosis in patients with hematologic malignancy: validation of the Aspergillus fumigatus antigen radioimmunoassay. J Infect Dis (1987) 1.44
Human plastin genes. Comparative gene structure, chromosome location, and differential expression in normal and neoplastic cells. J Biol Chem (1993) 1.43
Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation. Clin Cancer Res (2001) 1.42
Epigenetic gene inactivation induced by a cis-acting methylation center. J Biol Chem (1995) 1.42
A chemical and genetic approach together define the biological consequences of 3-methyladenine lesions in the mammalian genome. J Biol Chem (1998) 1.42
A cis-acting element accounts for a conserved methylation pattern upstream of the mouse adenine phosphoribosyltransferase gene. J Biol Chem (1993) 1.41
Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis (1986) 1.40
Mesenchymal stem cells: no longer second class marrow citizens. Nat Med (1999) 1.39
Experience with the use of the Codonics Safe Label System(™) to improve labelling compliance of anaesthesia drugs. Anaesth Intensive Care (2014) 1.39
Beetles, Competition, and Populations: An intricate ecological phenomenon is brought into the laboratory and studied as an experimental model. Science (1962) 1.34
O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells. J Clin Invest (1985) 1.33
Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. Arch Intern Med (1983) 1.31
DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis (1999) 1.28
The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase. Science (1993) 1.27
The primary function of a redundant Sp1 binding site in the mouse aprt gene promoter is to block epigenetic gene inactivation. Nucleic Acids Res (1998) 1.26
Isolation of super-repressor mutants in the histidine utilization system of Salmonella typhimurium. J Bacteriol (1975) 1.26
Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis (1995) 1.23
Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen. Cancer Chemother Pharmacol (2000) 1.23
Granulocyte colony-stimulating factor for clozapine-induced agranulocytosis. Lancet (1992) 1.21
O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair. Cancer Res (1999) 1.21
Cloning and characterization of a mouse 3-methyladenine/7-methyl-guanine/3-methylguanine DNA glycosylase cDNA whose gene maps to chromosome 11. Carcinogenesis (1993) 1.17
Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells. Mutat Res (2001) 1.15
Predictors of condom use in sexually active adolescents. J Adolesc Health (1992) 1.14
Temozolomide: the effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O(6)-alkylguanine-DNA-alkyltransferase. Clin Cancer Res (2001) 1.12
Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms. Br J Surg (2014) 1.11
LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum Gene Ther (1997) 1.11
Gestational age-dependent changes in circulating hematopoietic stem cells in newborn infants. J Lab Clin Med (1989) 1.10
Imbalanced base excision repair increases spontaneous mutation and alkylation sensitivity in Escherichia coli. J Bacteriol (1999) 1.10
Influence of S-adenosylmethionine pool size on spontaneous mutation, dam methylation, and cell growth of Escherichia coli. J Bacteriol (1999) 1.10
Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow. Cancer Res (1985) 1.10
Two-year experience with ureteral stones: extracorporeal shockwave lithotripsy v ureteroscopic manipulation. J Endourol (1998) 1.09
Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies. Bone Marrow Transplant (2011) 1.09
Limits on neutrino emission from gamma-ray bursts with the 40 string IceCube detector. Phys Rev Lett (2011) 1.08
Sexual partner selectiveness effects on homosexual HIV transmission dynamics. J Acquir Immune Defic Syndr (1988) 1.07
In vitro erythropoiesis from bone marrow-derived progenitors provides a physiological assay for toxic and mutagenic compounds. Proc Natl Acad Sci U S A (2007) 1.07
Cognitive and behavioral profile of the oculocerebrorenal syndrome of Lowe. Am J Med Genet (1993) 1.06
Twist-mediated activation of the NK-4 homeobox gene in the visceral mesoderm of Drosophila requires two distinct clusters of E-box regulatory elements. J Biol Chem (1997) 1.06
Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence. Int J Cancer (2001) 1.02
Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med (1984) 1.01
Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia. Am Rev Respir Dis (1985) 1.00
Influence of DNA structure on hypoxanthine and 1,N(6)-ethenoadenine removal by murine 3-methyladenine DNA glycosylase. Carcinogenesis (2000) 0.99
Preparation of multivesicular liposomes. Biochim Biophys Acta (1983) 0.99
Flour beetles: responses to extracts of their own pupae. Science (1970) 0.99
Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days. J Clin Oncol (2001) 0.98
Clozapine--deciphering the risks. N Engl J Med (1993) 0.98
Characterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: implications for drug resistance gene therapy. Hum Gene Ther (1999) 0.97
Fully expanded FMR1 CGG repeats exhibit a length- and differentiation-dependent instability in cell hybrids that is independent of DNA methylation. Hum Mol Genet (1999) 0.97
Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections. J Hematother (1997) 0.97
Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood (1995) 0.96
Screening methods for thyroid hormone disruptors. Environ Health Perspect (1999) 0.96
Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection. Blood (2000) 0.96
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96
Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanine. Carcinogenesis (1991) 0.95
The homeodomain transcription factor NK-4 acts as either a transcriptional activator or repressor and interacts with the p300 coactivator and the Groucho corepressor. J Biol Chem (1999) 0.95
Genetic alterations distinguish different types of ovarian tumors. Int J Cancer (1995) 0.95
Proteomic analysis of the genotoxicant methylazoxymethanol (MAM)-induced changes in the developing cerebellum. J Proteome Res (2006) 0.95
Alkylation-induced colon tumorigenesis in mice deficient in the Mgmt and Msh6 proteins. Oncogene (2008) 0.94
Increase in nitrosourea resistance in mammalian cells by retrovirally mediated gene transfer of bacterial O6-alkylguanine-DNA alkyltransferase. Cancer Res (1989) 0.94
The influence of DNA glycosylases on spontaneous mutation. Mutat Res (1998) 0.93
Retroviral transduction of a mutant methylguanine DNA methyltransferase gene into human CD34 cells confers resistance to O6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea. Proc Natl Acad Sci U S A (1996) 0.92
A novel family of mitochondrial plasmids associated with longevity mutants of Podospora anserina. J Biol Chem (1987) 0.92
Rapid repair of O6-methylguanine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomas. Cancer Res (1994) 0.91
Regulation of the hut operons of Salmonella typhimurium and Klebsiella aerogenes by the heterologous hut repressors. J Bacteriol (1975) 0.91
Mammalian 3-methyladenine DNA glycosylase protects against the toxicity and clastogenicity of certain chemotherapeutic DNA cross-linking agents. Cancer Res (1998) 0.91
Prospective evaluation of a Candida antigen detection test for invasive candidiasis in immunocompromised adult patients with cancer. Am J Med (1989) 0.90
Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair. Cell Death Dis (2012) 0.90
MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice. Oncogene (2001) 0.89